ENDLOS-TURBO CALL - CUREVAC | Real-time Boerse Frankfurt Warrants 05:04:51 2024-06-12 am EDT | ||
| 1.96 EUR | -2.97% |
|
| Current month | +30.32% | ||
| 1 month | +155.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
CUREVAC N.V.
Latest news about CUREVAC N.V.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-12 | 1.96 | -2.97% |
| 24-06-11 | 2.02 | -12.93% |
| 24-06-10 | 2.32 | +3.11% |
| 24-06-07 | 2.25 | -11.07% |
| 24-06-06 | 2.53 | +15.00% |
Real-time Boerse Frankfurt Warrants
Last update June 12, 2024 at 05:04 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | CUREVAC N.V. |
| Issuer | DZ BANK |
| WKN | DQ23Q5 |
| ISIN | DE000DQ23Q51 |
| Date issued | 2024-04-29 |
| Strike | 2.103 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 0.215 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.79 € |
|---|---|
| Lowest since issue | 0.24 € |
| Spread | 0.01 € |
| Spread % | 0.51% |
Company Profile
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve peopleâs lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Sector
-
Consensus: CureVac N.V.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
3.962
EUR
Average target price
8.728
EUR
Spread / Average Target
+120.27%
- Stock Market
- Certificates
- Certificat
